MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Negative Correlation Between Apathy and Performance on Memory Tasks in Patients with Idiopathic Parkinson’s Disease without Dementia.

    J. Felipe Ayala-Rico, C. Alberto Hurtado-González, S. Ospinta-Otalvaro, P. Andrea Gutiérrez-Lenis, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, K. Valbuena-Epiayu (Cali, Colombia)

    Objective: To establish the impact of apathy on memory functioning in patients with IPDWD. Background: Memory is one of the domains of neurocognitive functioning that…
  • 2025 International Congress

    Comparison of 3 Tests for Subjective Cognitive Complaints in Early Parkinson’s Disease

    R. Hoe, S. Ng, R. Chen, X. Choi, D. Heng, S. Neo, K. Tay, W. Au, E. Tan, L. Tan, Z. Xu (Singapore, Singapore)

    Objective: ​​​​​To compare 3 scales which have been used in literature to determine subjective cognitive complaints (SCC) in Parkinson’s disease (PD) and explore their relationship…
  • 2025 International Congress

    The Role of Depression and Anxiety in the Progression of Parkinson’s Disease

    N. Dahodwala, C. Hurley, T. Kapogiannis, H. Cho, C. Caspell-Garcia, D. Weintraub, R. Dobkin (Philadelphia, USA)

    Objective: To determine the association of depression and anxiety, and their treatment, with patient-reported outcomes (PROs) in a large, online, observational cohort of people with…
  • 2025 International Congress

    Duration of Illness and Response to Pimavanserin in Parkinson’s Disease Psychosis: Post-Hoc Analysis of Clinical Trial Data

    K. Dashtipour, A. Espay, M. Tagliati, G. Brunson, X. Feng, N. Rashid, L. Chrones (Loma Linda, USA)

    Objective: To examine individual responses to pimavanserin in patients with Parkinson’s disease psychosis (PDP) initiating treatment <6 vs ≥6 months and <12 vs ≥12 months…
  • 2025 International Congress

    Cerebral Vasoreactivity and Neuropsychiatric Features in Parkinson’s disease.

    M. Cansino Torres, D. Ortiz Zacarias, S. Castillo Torres, R. Lopez Soto, J. Trejo Ayala, A. Infante Valenzuela, F. Gongora Rivera, B. Chavez Luevanos, I. Estrada Bellmann (Monterrey, Mexico)

    Objective: To determine cerebral vasoreactivity (CVR) in Parkinson’s disease (PD) and its association with the neuropsychiatric features of the disease. Background: Non-motor symptoms in PD…
  • 2025 International Congress

    Poor sleep quality is one of the causes of cognitive decline in Parkinson’s disease (PD)-1

    K. Hasegawa, M. Miyashita, M. Sagawa, A. Kawanami (Kanagawa, Japan)

    Objective: The purpose of this study was to clarify the relationship between sleep disorders and cognitive function in PD by overnight electroencephalogram (EEG) and sleep…
  • 2025 International Congress

    Theta and Beta Oscillations Track Happiness and Surprise in the Subthalamic Nucleus After Reward Outcome

    S. Brener, G. Feng, C. Merrick, B. Blain, R. Rutledge, S. Little (New Haven, USA)

    Objective: To identify subcortical neural biomarkers of happiness and reward evaluation through sensing-enabled deep brain stimulation (DBS) in people with Parkinson’s Disease (PwPD). Background: Integrating…
  • 2025 International Congress

    Audit Of A Multidisciplinary Day Hospital For Parkinson’s and Falls (2019–2024)

    J. Ponce, C. Krishnan, A. Withanage, K. Fairhurst (New Lambton Heights, Australia)

    Objective: To assess a multidisciplinary hospital day service for Parkinson’s disease and fall-related concerns, identify service gaps, and evaluate its 5-year impact. Background: The Day…
  • 2025 International Congress

    Retrospective Analysis of the Neuropsychological Profiles of Parkinson’s Disease Patients Selected for Deep Brain Stimulation Surgery in Hawaii.

    E. Krening, A. Ford, M. Bruno, T. Umaki (Honolulu, USA)

    Objective: To investigate the neuropsychological profiles of White, Japanese, and other Asian American or Pacific Islander (OAAPI) patients with Parkinson’s disease (PD) identified as candidates…
  • 2025 International Congress

    Efficacy of adhering to a Ketogenic Diet in Parkinson’s Disease: a Systematic Review and Meta-Analysis

    G. Guindani Maia, V. Ritt Xavier, V. Serafim, M. Neto, L. Nardi Motta, V. Müller, I. Alicia Fink, AC. Sgarioni Viapiana, MF. Peruci Felippe, L. Bedatti Koehler, C. Rieder (Porto Alegre, Brazil)

    Objective: We aimed to analyse the efficacy of Ketogenic Diet (KD) in metabolic and motor characteristics of patients with Parkinson's Disease (PD). Background: Many studies…
  • « Previous Page
  • 1
  • …
  • 380
  • 381
  • 382
  • 383
  • 384
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley